Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
ASO Visual Abstract: Radiation Deescalation in Older Women with Early Stage ER+/HER2- Invasive Breast Cancer.
Journal: Annals of surgical oncology
Published: January 03, 2026
ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
Journal: Annals of surgical oncology
Published: December 04, 2025
Radiation De-Escalation in Older Women with Early-Stage ER+/HER2- Invasive Breast Cancer.
Journal: Annals of surgical oncology
Published: August 25, 2025
ASO Author Reflections: Moving Toward Evidence-Based Guidelines for Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer.
Journal: Annals of surgical oncology
Published: August 20, 2025
Breast cancer staging for patients with "low-risk" disease: Are they all the same?
Journal: Cancer
Published: July 29, 2025
Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
Journal: Annals of surgical oncology
Published: July 22, 2025
ERBB2-Low Expression by Race and Ethnicity Among Patients With Triple-Negative Breast Cancer.
Journal: JAMA network open
Published: June 11, 2025
Surgical Considerations for Patients With De Novo Metastatic Breast Cancer Based on Prognostic Group.
Journal: The Journal of surgical research
Published: May 27, 2025
Utility of the Singapore recurrence nomogram in a US cohort with a higher proportion of borderline and malignant phyllodes tumours.
Journal: Journal of clinical pathology
Published: May 13, 2025
Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.
Journal: Annals of surgical oncology
Published: April 28, 2025
Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 Neu-Negative Invasive Breast Cancer.
Journal: JCO clinical cancer informatics
Published: March 26, 2025
Survival outcomes after pathologic complete response with neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy: a retrospective national database study.
Journal: Breast cancer research and treatment
Published: March 24, 2025
Last Updated: 09/26/2026